Laxmi Dental Ltd
Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]
- Market Cap ₹ 1,326 Cr.
- Current Price ₹ 241
- High / Low ₹ 584 / 237
- Stock P/E 61.4
- Book Value ₹ 43.7
- Dividend Yield 0.00 %
- ROCE 17.3 %
- ROE 14.6 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 51.2% CAGR over last 5 years
Cons
- Stock is trading at 5.52 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 8.77% over past five years.
- Earnings include an other income of Rs.11.4 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE SmallCap BSE IPO BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 112 | 63 | 113 | 126 | 139 | 171 | 190 | |
| 110 | 59 | 109 | 119 | 128 | 144 | 160 | |
| Operating Profit | 3 | 4 | 4 | 6 | 12 | 27 | 31 |
| OPM % | 3% | 7% | 3% | 5% | 8% | 16% | 16% |
| 1 | 0 | 4 | 8 | 14 | 19 | 11 | |
| Interest | 3 | 3 | 3 | 4 | 5 | 4 | 2 |
| Depreciation | 6 | 6 | 7 | 9 | 9 | 10 | 11 |
| Profit before tax | -5 | -4 | -2 | 1 | 12 | 32 | 29 |
| Tax % | 5% | 9% | 118% | 0% | -85% | 18% | |
| -5 | -4 | -4 | 1 | 23 | 26 | 22 | |
| EPS in Rs | -155.57 | -140.95 | -142.58 | 46.12 | 737.58 | 4.69 | 4.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 15% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 51% |
| 3 Years: | 86% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 21% |
| Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 | 11 |
| Reserves | 44 | 40 | 36 | 28 | 51 | 212 | 229 |
| 36 | 36 | 41 | 42 | 53 | 5 | 5 | |
| 28 | 29 | 29 | 37 | 31 | 48 | 23 | |
| Total Liabilities | 109 | 105 | 106 | 108 | 136 | 276 | 268 |
| 38 | 41 | 32 | 35 | 33 | 40 | 40 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Investments | 16 | 16 | 17 | 14 | 14 | 17 | 69 |
| 54 | 48 | 57 | 59 | 89 | 219 | 158 | |
| Total Assets | 109 | 105 | 106 | 108 | 136 | 276 | 268 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 10 | 10 | -4 | 10 | 5 | 47 | |
| -15 | -9 | 3 | -6 | -6 | -49 | |
| 6 | -1 | 1 | -1 | -2 | 104 | |
| Net Cash Flow | 0 | 1 | -1 | 3 | -3 | 102 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 90 | 95 | 73 | 85 | 88 | 68 |
| Inventory Days | 189 | 377 | 195 | 162 | 196 | 132 |
| Days Payable | 184 | 310 | 147 | 151 | 82 | 196 |
| Cash Conversion Cycle | 95 | 162 | 120 | 95 | 201 | 4 |
| Working Capital Days | 21 | 9 | 27 | 20 | 71 | 72 |
| ROCE % | 0% | 1% | 6% | 19% | 17% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 (SEBI (LODR), Regulations 2015) - Board Comments On The Fine Levied By The National Stock Exchange Of India Limited)
1d - NSE fined Rs.5,000/day (total Rs.206,500 as of Dec 16, 2025) for Reg 23(9); waiver requested; CS appointed.
-
Appointment of Company Secretary and Compliance Officer
1d - Appointed Mr. Suman Saha as Company Secretary and Compliance Officer effective January 16, 2026.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ('Listing Regulations') For Change Of Name Of Statutory Auditors Of Laxmi Dental Limited ('The Company') Pursuant To Conversion From Partnership
Firm Into LLP
1d - Statutory auditor converted to LLP (M S K A & Associates LLP) effective Jan 13, 2026; engagement unchanged.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December, 2025
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Jan - Of Schedule of Analyst / Institutional Investor meetings under Regulation 30 of SEBI (LODR), Regulations 2015
Concalls
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptAI SummaryPPT
Leading Dental Company[1]
Laxmi Dental is the only end-to-end integrated dental products company in India. Based on FY23 revenue & PAT, the company is the largest and most profitable vertically integrated, indigenous B2B2C dental aligner solutions provider.